CoChat

Factors Associated With Potential Progressive Course of Primary Biliary Cholangitis: Data From Real-world US Database

The DOI matches its Crossref record, with a small difference in title or year; 28 of the 28 references it cites were found in a registry or an index.

Abstract

Background and Aims: Although relatively, primary biliary cholangitis (PBC) is an important cause of nonalcoholic chronic liver disease which may lead to liver transplantation. PBC patients with alkaline phosphatase (ALP) ≥1.5× the upper limit of normal (ULN) tend to have a more aggressive course. The study was designed to identify factors associated with ALP≥1.5×ULN or cirrhosis in PBC and to evaluate concomitant health care resource utilization. Methods: We used a large real-world database that contained comprehensive and continuous electronic medical recored/claims data from over 500 health care practices or systems from the United States. Results: Of 195 million patients included in the database, 36,317 were adults with PBC. After applying exclusion criteria, 15,875 patients comprised the final PBC cohort (63.0±13.5 y, 78% female, 71% privately insured, 5% covered by Medicaid, 57% with other autoimmune diseases, 46% with cirrhosis); 6083 (38%) had ALP≥1.5×ULN. Patients with ALP≥1.5×ULN were more frequently female, less covered by Medicaid, had more pruritus, cirrhosis, and other autoimmune diseases (P<0.05). In multivariate analysis, older age, female gender, the presence of other autoimmune diseases, and having compensated or decompensated cirrhosis were independently associated with having ALP≥1.5×ULN in PBC (P<0.05). In contrast, being male was associated with higher risk of cirrhosis in PBC [odds ratio 2.3 (95% confidence interval, 2.1-2.5)]. Patients with ALP≥1.5×ULN and/or with cirrhosis also incurred substantially more health care resource utilization (P<0.05). Conclusions: Many clinical, sociodemographic, and economic factors are associated with a potentially more aggressive profile of PBC with elevated ALP. These data may inform clinicians to implement management strategies to optimize care of these patients.

Overview

Integrity signals

Registry

Crossref · 10.1097/mcg.0000000000001120

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 28 references

Cited by

See all 19

Metadata

Authors
Younossi, Z. M., Stepanova, M., Golabi, P., Epstein, R. S., Strauss, M. E., Nader, F., & Racila, A.
Affiliations
  • Inova Health System (US)
  • Center for Outcomes Research in Liver Diseases (US)
  • Epstein Health, LLC, Woodcliff Lake, NJ
  • Intercept Pharmaceuticals (United States) (US)
Corresponding author
  • Younossi, Zobair M.
  • Racila, Andrei
Venue
Journal of Clinical Gastroenterology
Published
2019-10
Volume
53
Issue
9
Pages
693-698
ISSN
0192-0790 (ISSN-L)
OpenAlex
W2888641739
Cited by
18
References
28
Citations by year
2026: 3 · 2025: 5 · 2024: 3 · 2023: 2 · 2022: 2 · 2021: 1 · 2019: 2
FWCI
0.47
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Clinical Gastroenterology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
  • Health Sciences › Medicine › Rheumatology › IgG4-Related and Inflammatory Diseases
Keywords
primary biliary cirrhosis, alkaline phosphatase elevation, liver cirrhosis, disease progression, healthcare resource utilization, pruritus, autoimmune disease comorbidity, sex differences, Medicaid
MeSH terms
Age Factors, Aged, Alkaline Phosphatase, Autoimmune Diseases, Female, Humans, Liver Cirrhosis, Liver Cirrhosis, Biliary, Male, Middle Aged, Pruritus, Risk Factors, Sex Factors, Socioeconomic Factors, United States, Cohort Studies, Databases, Factual, Disease Progression, Electronic Health Records

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Factors Associated With Potential Progressive Course of Primary Biliary Cholangitis: Data From Real-world US Database. https://app.cochat.ai/papers/10.1097/mcg.0000000000001120
The paper
Younossi, Z. M., Stepanova, M., Golabi, P., Epstein, R. S., Strauss, M. E., Nader, F., & Racila, A. (2019). Factors Associated With Potential Progressive Course of Primary Biliary Cholangitis: Data From Real-world US Database. Journal of Clinical Gastroenterology. https://doi.org/10.1097/mcg.0000000000001120

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.